Key facts
- This page summarizes Rochel Soffer's Form 3 filing for Galera Therapeutics, Inc. (GRTX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 May 2024, 10:26.
Rochel Soffer - 16 Apr 2024 Form 3 Insider Report for Galera Therapeutics, Inc. (GRTX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GRTX
- Reported as of
- 16 Apr 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 May 2024, 10:26:45 UTC
- Next SEC filing
- 06 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rochel Soffer, Sole Member of Alpha Pharma Investments LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rochel Soffer filed Form 3 for Galera Therapeutics, Inc. (GRTX) on 16 May 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,178,137
- Date
- 16 Apr 2024
- Ownership
- Direct
- Footnotes
- F1, F2
GRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,750,000
- Date
- 16 Apr 2024
- Ownership
- See Footnote
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Of the 5,928,137 Shares reported, 3,178,137 shares of common stock are held by Rochel Soffer individually and 2,750,000 shares of common stock are held by Alpha Pharma Investments LLC (collectively, the "Reporting Persons"). Rochel Soffer, as the sole member and beneficiary of Alpha Pharma Investments LLC has voting and dispositive power of Alpha Pharma Investments LLC.
Footnote F2
The Reporting Persons disclaims beneficial ownership of all securities owned by Yair Schneid, the spouse of Rochel Soffer, except to the extent of their pecuniary interest therein, if any.